글로벌 단일 세포 분석 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

단일 세포 분석 시장 분석

최근 몇 년 동안 전 세계적으로 다양한 암 사례가 급증했습니다. GLOBOCAN에 따르면  암  사례는 2020년 1,930만 건, 암 사망자 1,000만 명에서 2040년까지 약 3,000만 건으로 증가할 것으로 예상됩니다. 결과적으로 유병률 증가는 암 연구 투자와 생명공학 및 바이오제약의 성장으로 이어질 것입니다. 따라서 이 시장은 예상 기간 내에 수익성 있는 성장 기회를 보일 것으로 추정됩니다.

단일 세포 분석 시장 규모

글로벌 단일 세포 분석 시장 규모는 2023년에 41억 4천만 달러로 평가되었으며, 2031년까지 132억 1천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 15.60%입니다.

보고 범위 및 시장 세분화       

단일 세포 분석 시장 정의

단일 세포 분석은 단일 세포 수준에서 유전체, 전사체학, 단백체학 및 대사체학을 연구하는 것으로, 암 연구와 다양한 만성 및 감염성 질환 치료에 사용됩니다. 이는 인구를 밝히고, 관심 있는 시장 하위 인구를 식별하고, 개별 세포의 고유한 특성을 발견하고, 이질성을 발견하는 데 유용합니다.

단일 세포 분석 시장 동향

이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래와 같이 자세히 논의됩니다.

운전자

• 전 세계적으로 증가하는 암 부담

암 유병률 증가는 이 시장의 성장을 이끄는 가장 중요한 요인입니다. 암으로 이어지는 성장 요인도 시장의 전반적인 성장을 가속화할 것으로 예상됩니다.

• 급속한 경제 성장

 급속한 도시화와 디지털화, 향상된 의료 인프라, 그리고 인식의 성장 역시 시장 성장을 촉진할 것으로 예상됩니다.

또한, 줄기세포 연구의 성장과 결합된 개인화된 의학에 대한 집중이 커지면서 시장 성장이 촉진될 것으로 예상됩니다. 게다가, 단일 세포 분석 장치의 채택이 증가함에 따라 예측 기간 내에 시장 성장이 완화됩니다.

기회

• 증가하는 투자와 발전

또한, 단일 세포 분석 제품의 기술적 발전과 제약 및 생명공학 산업 전반의 연구 개발 활동 증가는 시장에 수익성 있는 기회를 창출할 것으로 추산됩니다. 의료 진단 분야에 투자와 정부 기금이 증가하고 단일 세포 증폭 및 조작 기술 기술이 등장하여 분석에서 고처리량 기술이 적용됨에 따라 시장에 수많은 성장 기회가 제공될 것입니다.

제약/도전 

• 높은 비용

장비 가격이 비싸서 예산 제약으로 인해 다양한 연구 및 학술 실험실에서 구매하기 어렵고, 이는 시장 성장을 방해할 것으로 예상됩니다.

• Technical Limitations

Also, various technical limitations are projected to challenge the single cell analysis market in the forecast period of 2024-2031.

This single cell analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the single cell analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Single Cell Analysis Market

The single cell analysis market was positively impacted by the outbreak of COVID-19. The pandemic's economic and social toll has driven governments around the world to increase funding for vaccine development and production, resulting in a rise in the use of single-cell analysis products for COVID-19 research. Although the imposition various restrictions by the government affected the overall production and sales, but the increased single-cell analysis products demand. To better construct prognostic and diagnostic indicators and establish appropriate therapeutic approaches for patients with severe disease presentation, a better understanding of the host immune response throughout disease progression is critical. The single-cell analysis can help researchers better understand immune cells on a single-cell level and how functional cells contribute to immune protection and pathogenesis, allowing for the development of more effective vaccines and immunotherapies.

Therefore, the increased product demand and ongoing research activities (by exploring the application of the single-cell analysis technique in the SARS-CoV2) during the COVID-19, the market is expected to have good opportunities for growth during the pandemic.

Single Cell Analysis Market Scope

The single cell analysis market is segmented on the basis of product, cell type, technique, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Consumables
• Instruments

On the basis of product, the single cell analysis market is segmented into consumables and instruments. The consumables are sub-segmented into beads, microplates, reagents, assay kits and other consumables. Assay kits further include immunoassays and cell-based assays. The other consumables include culture dishes, flasks, tubes, cuvettes, cryovials, filtration apparatus, petri dishes, inserts and discs. The instruments are sub-segmented into flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems, microarrays and other instruments.

Cell Type

• Animal Cells
• Microbial Cells
• Human Cells

On the basis of cell type, the single cell analysis market is segmented into animal cells, microbial cells and human cells.

Technique

• Flow Cytometry
• Next-Generation Sequencing
• Polymerase Chain Reaction, Microscopy
• Mass Spectrometry
• Other Techniques

On the basis of technique, the single cell analysis market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry and other techniques.

Application

• Research Applications
• Medical Applications

On the basis of application, the single cell analysis market is segmented into research applications and medical applications.

End User

• Hospitals and Diagnostic Laboratories
• Cell Banks and IVF centers
• Biotechnology and Biopharmaceutical Companies
• Research and Academic Laboratories

On the basis of end user, the single cell analysis market is bifurcated into hospitals and diagnostic laboratories, cell banks and IVF centers, biotechnology and biopharmaceutical companies and research and academic laboratories.

Single Cell Analysis Market Regional Analysis

The single cell analysis market is analyzed and market size insights and trends are provided by country, product, cell type, technique, application and end user as referenced above.

The countries covered in the single cell analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the single cell analysis market because of the developed healthcare infrastructure, rising expenditure on personalized medicine and increasing prevalence of cancer within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rapidly developing healthcare infrastructure and increasing disposable income within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The single cell analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for single cell analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the single cell analysis market. The data is available for historic period 2010-2020.

Single Cell Analysis Market Share

The single cell analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to single cell analysis market.

Single Cell Analysis Market Leaders Operating in the Market Are:

• BD (U.S.)
• Danaher (U.S.)
• Merck KGAA (Germany)
• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific Inc., (U.S.)
• Luminex Corporation (U.S.)
• 10x Genomics (U.S.)
• Promega Corporation (U.S.)
• Illumina, Inc. (U.S.)
• Bio-Rad Laboratories (U.S.)
• Fluidigm (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Tecan Trading AG (Switzerland)
• Sartorius AG (Germany)
• Takara Bio Inc., (Japan)
• Fluxion Biosciences Inc., (U.S.)
• Menarini Silicon Biosystems (Italy)
• bioMérieux (France)
• Oxford Nanopore Technologies plc. (U.K)
• Cytek Biosciences (U.S.)
• Corning Incorporated (U.S.)
• Apogee Flow Systems Ltd. (U.K)
• NanoCellect Biomedical (U.S.)
• Rarecyte Inc (U.S.)
• On-chip Biotechnologies Co., Ltd. (Japan)

Latest Developments in Single Cell Analysis Market

• In October 2020, BD, a leading global medical technology company, received US FDA's 510 (K) clearance for its BD FACSLyric Flow Cytometer with Newly Integrated BD FACSDuet Sample Preparation System. The new integrated system allows clinical laboratories to fully automate the sample to answer process, decreasing mistakes and reducing the number of manual user contacts necessary to execute BD FACSLyricTM Flow Cytometer assays

SKU-10805